APA (7th ed.) Citation

N. A. Avxentyev, M. Yu. Frolov, & A. S. Makarov. (2018). Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia. IRBIS LLC.

Chicago Style (17th ed.) Citation

N. A. Avxentyev, M. Yu. Frolov, and A. S. Makarov. Pharmacoeconomic Analysis of Treatment with Nilotinib as the Second Line Therapy in Patients with Chronic Myeloid Leukemia. IRBIS LLC, 2018.

MLA (9th ed.) Citation

N. A. Avxentyev, et al. Pharmacoeconomic Analysis of Treatment with Nilotinib as the Second Line Therapy in Patients with Chronic Myeloid Leukemia. IRBIS LLC, 2018.